Back to Search
JONATHAN WISCHHUSEN, M.D.
M.D.
Medical Oncology Physician
NPI: 1770930588IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
277784(MA)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
268191(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
277784(MA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Class of 2016
Research & Publications (20)
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
PMID 17768067·Semin Cancer Biol·2007
6-review
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
PMID 15977644·J Neuropathol Exp Neurol·2005
4-observational
Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system.
PMID 15833357·J Neuroimmunol·2005
4-observational
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death.
PMID 14614447·Oncogene·2003
8-other
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
PMID 11980654·Cancer Res·2002
8-other
Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
PMID 19578778·Oncol Rep·2009
8-other
Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?
PMID 19088701·G Ital Dermatol Venereol·2009
6-review
Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
PMID 18975328·Arthritis Rheum·2008
8-other
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
PMID 18687514·Eur J Obstet Gynecol Reprod Biol·2008
8-other
Temozolomide preferentially depletes cancer stem cells in glioblastoma.
PMID 18632623·Cancer Res·2008
8-other
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
PMID 18490733·J Immunol·2008
8-other
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
PMID 18371181·Brain Pathol·2008
8-other
A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
PMID 18202704·Cell Death Differ·2008
7-preclinical
Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
PMID 17675252·J Neuroimmunol·2007
8-other
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
PMID 17483311·Cancer Res·2007
7-preclinical
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
PMID 16891318·Brain·2006
8-other
Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.
PMID 16585213·Cancer Res·2006
7-preclinical
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
PMID 16405512·J Neurochem·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22 PATRIOT PL
FOXBOROUGH, MA 02035 - Phone
- (508) 543-1700
Quick Facts
- NPI
- 1770930588
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile